Transforming Growth Factor Betal and Beta2 Induce Down-Modulation of Thrombomodulin in Human Umbilical Vein Endothelial Cells

Summary To investigate the effects of transforming growth factor-betas (TGF-βs) on endothelial anticoagulant activity, we assayed thrombomodulin (TM) activity and antigen levels of human umbilical vein endothelial cells (HUVECs) incubated with TGF-βs in vitro. TGF-β1 suppressed surface TM activity and surface TM antigen levels maximally 12 h after incubation in dose-dependent manners. TGF-β2 was almost equipotent with TGF-β1 for the suppression of them. Both TGF-βs suppressed total TM antigen level in HUVECs, and the time course of the suppression was similar to that of the cell surface TM antigen level. The maximal reductions of TM mRNA levels by TGF-βs were observed at several hours ahead of those observed in both surface and total TM antigen levels, suggesting that the TGF-β-mediated suppression of TM antigen of HUVECs is primarily regulated at the TM mRNA level. Our present work suggests that the down-modulation of TM level induced by TGF-βs in HUVECs contributes in vivo to promoting the thrombogenesis either at the sites of injury of vessel walls, such as atherosclerotic lesions where TGF-β1 is released from platelets, smooth muscle cells and monocytes, or at neovascular walls in tumors secreting TGF-β2.

[1]  J. Massagué,et al.  Betaglycan presents ligand to the TGFβ signaling receptor , 1993, Cell.

[2]  Jeffrey L. Wrana,et al.  TGFβ signals through a heteromeric protein kinase receptor complex , 1992, Cell.

[3]  J. Massagué,et al.  Endoglin is a component of the transforming growth factor-beta receptor system in human endothelial cells. , 1992, The Journal of biological chemistry.

[4]  S. Horie,et al.  Retinoic acid stimulates expression of thrombomodulin, a cell surface anticoagulant glycoprotein, on human endothelial cells. Differences between up-regulation of thrombomodulin by retinoic acid and cyclic AMP. , 1992, The Biochemical journal.

[5]  S. S. Huang,et al.  Expression of a new type high molecular weight receptor (type V receptor) of transforming growth factor beta in normal and transformed cells. , 1991, Biochemical and biophysical research communications.

[6]  K. Hirokawa,et al.  Up-regulation of thrombomodulin by activation of histamine H1-receptors in human umbilical-vein endothelial cells in vitro. , 1991, The Biochemical journal.

[7]  N. Aoki,et al.  Regulatory mechanisms for thrombomodulin expression in human umbilical vein endothelial cells in vitro , 1991, Journal of cellular physiology.

[8]  T. Hayashi,et al.  One-step sandwich enzyme immunoassay for soluble human thrombomodulin using monoclonal antibodies. , 1990, Clinica chimica acta; international journal of clinical chemistry.

[9]  C. Esmon,et al.  The roles of protein C and thrombomodulin in the regulation of blood coagulation. , 1984, The Journal of biological chemistry.

[10]  S. Mohan,et al.  Comparison of the biological actions of TGF beta‐1 and TGF beta‐2: Differential activity in endothelial cells , 1988, Journal of cellular physiology.

[11]  O. Ottmann,et al.  Differential proliferative effects of transforming growth factor-beta on human hematopoietic progenitor cells. , 1988, Journal of immunology.

[12]  M. Sporn,et al.  Transforming growth factor beta: biochemistry and roles in embryogenesis, tissue repair and remodeling, and carcinogenesis. , 1988, Recent progress in hormone research.

[13]  B. Haendler,et al.  Complementary DNA for human glioblastoma‐derived T cell suppressor factor, a novel member of the transforming growth factor‐beta gene family. , 1987, The EMBO journal.

[14]  A. Bassols,et al.  Two forms of transforming growth factor-β distinguished by multipotential haematopoietic progenitor cells , 1987, Nature.

[15]  D. Moscatelli,et al.  The opposing effects of basic fibroblast growth factor and transforming growth factor beta on the regulation of plasminogen activator activity in capillary endothelial cells , 1987, The Journal of cell biology.

[16]  S. Yamamoto,et al.  Structure and expression of human thrombomodulin, a thrombin receptor on endothelium acting as a cofactor for protein C activation. , 1987, The EMBO journal.

[17]  K. Frei,et al.  T cell suppressor factor from human glioblastoma cells is a 12.5‐kd protein closely related to transforming growth factor‐beta. , 1987, The EMBO journal.

[18]  H. Marquardt,et al.  Human transforming growth factor type beta 2: production by a prostatic adenocarcinoma cell line, purification, and initial characterization. , 1987, Biochemistry.

[19]  J. Massagué,et al.  The transforming growth factor-β system, a complex pattern of cross-reactive ligands and receptors , 1987, Cell.

[20]  C. Esmon,et al.  Endotoxin enhances tissue factor and suppresses thrombomodulin expression of human vascular endothelium in vitro. , 1987, The Journal of clinical investigation.

[21]  W. Birchmeier,et al.  Transforming growth factor-beta inhibits endothelial cell proliferation. , 1986, Biochemical and biophysical research communications.

[22]  D. Stern,et al.  Interleukin 1 induces endothelial cell procoagulant while suppressing cell-surface anticoagulant activity. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[23]  R. Ross.  The pathogenesis of atherosclerosis--an update. , 1986, The New England journal of medicine.

[24]  E. Jaffe,et al.  Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. , 1973, The Journal of clinical investigation.